Joint Lab Venture Targets China
Lawke Links, Cordium Links new joint venture with a Chinese organization, will bring a full range of ECG core lab services to China.
Cordium Links, a provider of centralized cardiac safety monitoring, announced that it has established a joint venture with a Chinese organization to deliver core lab services to drug development companies performing cardiac safety evaluation as part of clinical research in China. The joint venture is called Lawke Links. It aims to bring a full range of ECG core lab services, including project management, site support, and centralized ECG data analysis to China. Lawke Links will provide FDA- and ICH-compliant cardiac safety analysis to biopharm companies conducting Phase I–IV multinational trials.
Lawke Links will donate 9% of the value of work performed on all of its contracts through June 2009 to support the reconstruction and humanitarian efforts associated with the recent earthquake that devastated the country.
In addition to ECG core lab services, Lawke Links has established an exclusive relationship with Peking Union Lawke Biomedical Development Limited (PUL) to provide central lab services. Jian Ho, MD, PhD, chief executive officer and medical director at PUL, will initially head up project management and site support for Lawke Links in China. "It's an honor to bring the resources of one of the leading core labs in the world to China," said Dr. Ho in a press release. "We will be the first and only lab that provides a full range of core lab and central lab services to the growing Chinese market."
China represents one of the world's fastest growing markets for clinical trials. According to the Tufts Center for Drug Development, the market for clinical trials in China has grown 43% in the past three years.
Lawke Links will offer all the advanced services that Cordium Links provides its U.S. customers, including 12-lead digital ECG, Holter monitoring, centralized data management, and QT/QTc analysis and reporting. As an "in country" core lab, Lawke Links hopes to eliminate the difficulty sponsors currently face in sending equipment and locating expertise for trials conducted in China. According to Cordium Links, ECG core labs that currently support trials in China typically send equipment and technical expertise, which adds time and expense. In addition, sponsors often must pay for the use of equipment shipped to China until it is returned.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Regulatory Compliance With eCOAs
April 26th 2024In the fourth and final part of this video interview with ACT editor Andy Studna, Melissa Mooney, director, eCOA sales engineering, IQVIA discusses how the regulatory stance on electronic clinical outcome assessments has changed over the years and what it could look like in the future.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.
Using Patient Reported Outcomes in Dermatology Trials
April 25th 2024In part 3 of this video interview with ACT editor Andy Studna, Melissa Mooney, director, eCOA sales engineering, IQVIA sheds light on the unique challenges of dermatology trials and how clinical outcome assessments can be implemented in them.
